All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
Results
6 results
Evaluation of the reimbursement for hearing aids and implants in hearing loss
KCE Reports 333C (2020)
In our country around 455,000 people use hearing aids due to hearing loss that can range from slight to very severe. Our health insurance sees to it that everyone can have access to the (sometimes partial) reimbursement of the cost of these devices, but the budget that this represents for the INAMI (National Sickness and Invalidity Insurance Institute) has more than doubled in ten years. It is chiefly the costs associated with increasingly sophisticated (partially or wholly) implantable hearing aids that are constantly rising.
Read more
Asylum seekers in Belgium: options for a more equitable access to health care. A stakeholder consultation
KCE Reports 319C (2019, 2ed.)
Any migrant who arrives in Belgium and seeks asylum automatically receives access to healthcare for the duration of the asylum procedures. However, several Belgian and international reports have highlighted the fact that access to this care is not equal for all asylum seekers.
Read more
Proposals for a more effective antibiotic policy in Belgium
KCE Reports 311C (2019)The inappropriate use of antibiotics has led to an increasing resistance to bacteria, to the extent that all the benefits of these drugs risk being wiped out. To tackle this resistance problem, the prudent use of antibiotics is a priority.
Read more
Exploratory steps for the formulation of Belgian health system targets
KCE Reports 292C (2017)KCE was asked to compile an inventory of all health goals defined at the federal level, as recommended by the World Health Organization (WHO). There are already a number of them, but they are quite disparate. It is therefore necessary to give them a common thread and a framework, for example via a platform that coordinates the policy of setting objectives.
Read more
Horizon scanning for pharmaceuticals: proposal for the BeNeLuxA collaboration
KCE Reports 283C (2017)
The ‘BeNeLuxA Collaboration’ is the result of the willingness of the Belgian, Dutch, Luxembourg and Austrian governments to collaborate on drug policy. In this context, the KCE has been asked to study the possibilities of setting up a common Horizon Scanning system for pharmaceutical products.
Read more
Policies for Rare Diseases and Orphan Drugs
KCE Reports 112C (2009)
Read more